##4080443
Granulocytic	granulocytic	jj_nn1
sarcoma	sarcoma	nn1
of	of	io
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
is	be	vbz
exceedingly	exceedingly	rr
rare	rare	jj
.	.	y
We	we	ppis2
describe	describe	vv0
the	the	at
case	case	nn1
of	of	io
a	a	at1
55-year-old	55-year-old	jj
man	man	nn1
who	who	pnqs
presented	present	vvd
with	with	iw
an	a	at1
intranasal	intranasal	jj
mass	mass	nn1_jj
that	that	cst_dd1
was	be	vbdz
later	later	rrr
diagnosed	diagnose	vvn_vvd
as	as	ii
a	a	at1
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
.	.	y
The	the	at
mass	mass	nn1
was	be	vbdz
treated	treat	vvn
with	with	iw
rapid	rapid	jj
initiation	initiation	nn1
of	of	io
chemotherapy	chemotherapy	nn1
,	,	y
which	which	ddq
produced	produce	vvd
a	a	at1
substantial	substantial	jj
decrease	decrease	nn1
in	in	ii
tumor	tumor	nn1
bulk	bulk	nn1
.	.	y
Granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
is	be	vbz
often	often	rr
mistaken	mistake	vvn
for	for	if
lymphoma	lymphoma	nn1
or	or	cc
other	other	jj
poorly	poorly	rr_jj
differentiated	differentiate	vvn_vvd_jj%
malignancies	malignancy	nn2
,	,	y
and	and	cc
the	the	at
correct	correct	jj
diagnosis	diagnosis	nn1
requires	require	vvz
a	a	at1
high	high	jj
index	index	nn1
of	of	io
clinical	clinical	jj
suspicion	suspicion	nn1
.	.	y
Granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
is	be	vbz
synonymous	synonymous	jj
with	with	iw
extramedullary	extramedullary	jj
myeloid	myeloid	jj_nn1
sarcoma	sarcoma	nn1
,	,	y
myeloblastoma	myeloblastoma	nn1
,	,	y
and	and	cc
chloroma	chloroma	nn1
.	.	y
These	these	dd2
solid	solid	jj
tumors	tumor	nn2
are	be	vbr
composed	compose	vvn
of	of	io
leukemic	leukemic	jj
cells	cell	nn2
.	.	y
They	they	pphs2
commonly	commonly	rr
present	present	jj_vv0@
in	in	ii
the	the	at
soft	soft	jj
tissues	tissue	nn2
of	of	io
the	the	at
head	head	nn1
and	and	cc
neck	neck	nn1
and	and	cc
in	in	ii
intracranial	intracranial	jj
sites	site	nn2
,	,	y
although	although	cs
they	they	pphs2
may	may	vm
arise	arise	vvi
anywhere	anywhere	rl
in	in	ii
the	the	at
body	body	nn1
.	.	y
The	the	at
diagnosis	diagnosis	nn1
is	be	vbz
made	make	vvn
clinically	clinically	rr
on	on	ii
the	the	at
basis	basis	nn1
of	of	io
a	a	at1
combination	combination	nn1
of	of	io
location	location	nn1
,	,	y
pathologic	pathologic	jj
appearance	appearance	nn1
,	,	y
and	and	cc
a	a	at1
concurrent	concurrent	jj
diagnosis	diagnosis	nn1
of	of	io
acute	acute	jj
leukemia	leukemia	nn1
or	or	cc
myelodysplastic	myelodysplastic	jj
syndrome	syndrome	nn1
.	.	y
Granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
may	may	vm
be	be	vbi
seen	see	vvn
in	in	ii
multiple	multiple	jj
clinical	clinical	jj
scenarios	scenario	nn2
:	:	y
as	as	ii_csa
a	a	at1
precursor	precursor	nn1
of	of	io
acute	acute	jj
myelogenous	myelogenous	jj
leukemia	leukemia	nn1
in	in	ii
nonleukemic	nonleukemic	jj
patients	patient	nn2
,	,	y
as	as	csa_ii
a	a	at1
herald	herald	nn1
of	of	io
impending	impending	jj
blast	blast	nn1
crisis	crisis	nn1
in	in	ii
chronic	chronic	jj
myelogenous	myelogenous	jj
leukemia	leukemia	nn1
,	,	y
as	as	csa_ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
distinct	distinct	jj
tissue	tissue	nn1
manifestation	manifestation	nn1
in	in	ii
patients	patient	nn2
already	already	rr
diagnosed	diagnose	vvn_vvd
with	with	iw
acute	acute	jj
myelogenous	myelogenous	jj
leukemia.	leukemia	nnu
n1	n1	fo
Granulocytic	granulocytic	jj_nn1
sarcoma	sarcoma	nn1
may	may	vm
also	also	rr
present	present	vvi
in	in	ii_rp@
nonleukemic	nonleukemic	jj
patients	patient	nn2
,	,	y
who	who	pnqs
tend	tend	vv0
to	to	to
have	have	vhi
a	a	at1
better	better	jjr
prognosis	prognosis	nn1
if	if	cs
diagnosed	diagnose	vvn
and	and	cc
treated	treat	vvn
promptly.	promptly	nnu
n2	n2	fo
Granulocytic	granulocytic	jj_nn1
sarcomas	sarcoma	nn2
have	have	vh0
been	be	vbn
reported	report	vvn
frequently	frequently	rr
in	in	ii
the	the	at
orbits	orbit	nn2
n3	n3	fo
and	and	cc
less	less	rgr
frequently	frequently	rr
in	in	ii
various	various	jj
other	other	jj
sites	site	nn2
,	,	y
including	including	ii_vvg@
the	the	at
gingiva	gingiva	nn1
,	,	y
n4	n4	fo
maxilla	maxilla	nn1
,	,	y
n5	n5	fo
parotid	parotid	jj_nn1
gland	gland	nn1
,	,	y
(	(	y
n6-n8	n6-n8	nn1_jj
)	)	y
temporal	temporal	jj
bone	bone	nn1
,	,	y
n8	n8	fo
temporal	temporal	jj
lobe	lobe	nn1
of	of	io
the	the	at
brain	brain	nn1
,	,	y
n9	n9	fo
cerebellopontine	cerebellopontine	jj_nn1
angle	angle	nn1
(	(	y
causing	cause	vvg
sudden	sudden	jj
sensorineural	sensorineural	jj_nn1
hearing	hearing	nn1
loss	loss	nn1
)	)	y
,	,	y
n10	n10	fo
and	and	cc
masseter	masseter	jjr
muscle.	muscle	nnu
n11	n11	fo
While	while	cs
there	there	ex
are	be	vbr
reports	report	nn2
of	of	io
these	these	dd2
tumors	tumor	nn2
occurring	occur	vvg
in	in	ii
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
n12	n12	fo
and	and	cc
paranasal	paranasal	nn1_jj@
sinuses	sinus	nn2_vvz
,	,	y
n13	n13	fo
such	such	da
cases	case	nn2
are	be	vbr
thought	think	vvn
to	to	to
be	be	vbi
exceedingly	exceedingly	rr
rare	rare	jj
.	.	y
We	we	ppis2
describe	describe	vv0
a	a	at1
new	new	jj
case	case	nn1
of	of	io
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
of	of	io
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
.	.	y
Case	case	nn1
report	report	nn1
A	a	zz1
55-year-old	55-year-old	jj
man	man	nn1
was	be	vbdz
referred	refer	vvn
to	to	ii
our	our	appge
ENT	ent	jj_nn1
clinic	clinic	nn1
for	for	if
evaluation	evaluation	nn1
of	of	io
a	a	at1
left-sided	left-sided	jj
nasal	nasal	jj
mass	mass	nn1
.	.	y
He	he	pphs1
had	have	vhd
originally	originally	rr
presented	present	vvn
to	to	ii
his	his	appge
primary	primary	jj_nn1
care	care	nn1
physician	physician	nn1
and	and	cc
reported	report	vvd_vvn
a	a	at1
1-month	1-month	jj_nnt1
history	history	nn1
of	of	io
headaches	headache	nn2
and	and	cc
double	double	jj
vision	vision	nn1
that	that	cst
had	have	vhd
become	become	vvn@
worse	bad	rrr@_jjr
during	during	ii
the	the	at
preceding	preceding	jj
2	2	mc
weeks	week	nnt2
.	.	y
He	he	pphs1
also	also	rr
reported	report	vvd
that	that	cst
his	his	appge
left	left	jj
eye	eye	nn1
had	have	vhd
been	be	vbn
swollen	swell	vvn
for	for	if
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
pronounced	pronounce	vvn_vvd
over	over	ii_rp
the	the	at
past	past	jj_nn1
few	few	da2
weeks	week	nnt2
.	.	y
Findings	finding	nn2
on	on	ii
a	a	at1
review	review	nn1
of	of	io
systems	system	nn2
were	be	vbdr
positive	positive	jj
for	for	if
occasional	occasional	jj
left-sided	left-sided	jj_nn1
epistaxis	epistaxis	nn1
and	and	cc
left-sided	left-sided	jj
nasal	nasal	jj
airway	airway	nn1
obstruction	obstruction	nn1
.	.	y
The	the	at
patient	patient	nn1
denied	deny	vvd_vvn
any	any	dd
decrease	decrease	nn1_vv0
in	in	ii
visual	visual	jj
acuity	acuity	nn1
or	or	cc
weight	weight	nn1
loss	loss	nn1
.	.	y
Otherwise	otherwise	rr
,	,	y
his	his	appge
medical	medical	jj
history	history	nn1
was	be	vbdz
significant	significant	jj
for	for	if
Philadelphia	philadelphia	np1
chromosome-positive	chromosome-positive	jj
chronic	chronic	jj
myelogenous	myelogenous	jj
leukemia	leukemia	nn1
,	,	y
which	which	ddq
had	have	vhd
been	be	vbn
treated	treat	vvn
with	with	iw
oral	oral	jj
imatinib	imatinib	nn1
.	.	y
Physical	physical	jj
examination	examination	nn1
revealed	reveal	vvd_vvn
left-sided	left-sided	jj
proptosis	proptosis	nn1
with	with	iw
periorbital	periorbital	jj
edema	edema	nn1
and	and	cc
erythema	erythema	nn1
and	and	cc
a	a	at1
left-sided	left-sided	jj
cranial	cranial	jj
nerve	nerve	nn1
VI	vi	mc
palsy	palsy	nn1
.	.	y
Endoscopic	endoscopic	jj
examination	examination	nn1
of	of	io
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
detected	detect	vvd_vvn
a	a	at1
homogeneous	homogeneous	jj
,	,	y
nonpulsatile	nonpulsatile	jj
,	,	y
nonulcerated	nonulcerated	vvd_jj@
mass	mass	nn1_jj
between	between	ii
the	the	at
left	left	jj
middle	middle	jj_nn1
turbinate	turbinate	nn1_jj
and	and	cc
the	the	at
nasal	nasal	jj
septum	septum	nn1
that	that	cst
appeared	appear	vvd
to	to	to
be	be	vbi
superiorly	superiorly	rr
based	base	vvn
.	.	y
Computed	computed	jj@_vvn
tomography	tomography	nn1
(	(	y
CT	ct	np1@_nn1
)	)	y
and	and	cc
magnetic	magnetic	jj
resonance	resonance	nn1
imaging	imaging	nn1_vvg
(	(	y
MRI	mri	np1
)	)	y
identified	identify	vvd@_vvn
a	a	at1
soft-tissue	soft-tissue	jj_nn1
mass	mass	nn1_jj
that	that	cst
involved	involve	vvd
the	the	at
entire	entire	jj
left	left	jj
nasal	nasal	jj
cavity	cavity	nn1
,	,	y
the	the	at
ethmoid	ethmoid	nn1_jj
and	and	cc
frontal	frontal	jj
sinuses	sinus	nn2
,	,	y
and	and	cc
part	part	nn1
of	of	io
the	the	at
right	right	jj_nn1
ethmoid	ethmoid	jj_nn1
cavity	cavity	nn1
(	(	y
figure	figure	nn1_vv0@
1	1	mc1
)	)	y
.	.	y
Bony	bony	jj
erosion	erosion	nn1
of	of	io
the	the	at
anterior	anterior	jj
cribriform	cribriform	jj
plate	plate	nn1
and	and	cc
left	left	jj
lamina	lamina	nn1
papyracea	papyracea	nn1
was	be	vbdz
also	also	rr
noted	note	vvn_vvd
on	on	ii
review	review	nn1
of	of	io
the	the	at
films	film	nn2
.	.	y
Figure	figure	vv0@_nn1
1	1	mc1
.	.	y
A	a	zz1
:	:	y
Noncontrast	noncontrast	vv0_np1_nn1
CT	ct	nn1
of	of	io
the	the	at
paranasal	paranasal	nn1_jj@
sinuses	sinus	nn2_vvz
shows	show	vvz
the	the	at
left	left	jj
sinonasal	sinonasal	nn1_jj@
mass	mass	nn1
.	.	y
B	b	zz1_np1@
:	:	y
T2-weighted	t2-weighted	jj
MRI	mri	nn1_nn2_np1
shows	show	vvz
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
endoscopic	endoscopic	jj
surgical	surgical	jj
biopsy	biopsy	nn1
was	be	vbdz
performed	perform	vvn
in	in	ii
the	the	at
operating	operating	nn1
room	room	nn1
(	(	y
figure	figure	nn1
2	2	mc
)	)	y
.	.	y
Pathologic	pathologic	jj
analysis	analysis	nn1
of	of	io
the	the	at
specimen	specimen	nn1
revealed	reveal	vvd_vvn
that	that	cst
the	the	at
mass	mass	nn1
was	be	vbdz
a	a	at1
high-grade	high-grade	jj
malignant	malignant	jj_nn1
blastic	blastic	jj
neoplasm	neoplasm	nn1
with	with	iw
myeloid	myeloid	nn1_jj
,	,	y
T-lymphoblastic	t-lymphoblastic	jj_nn1@
,	,	y
and	and	cc
B-lymphoblastic	b-lymphoblastic	jj
differentiation	differentiation	nn1
--		nn1
that	that	rex21
is	is	rex22
,	,	y
a	a	at1
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
(	(	y
figure	figure	nn1
3	3	mc
)	)	y
.	.	y
Histologic	histologic	jj
examination	examination	nn1
of	of	io
a	a	at1
subsequent	subsequent	jj
bone	bone	nn1
marrow	marrow	nn1
biopsy	biopsy	nn1
confirmed	confirm	vvd_vvn
that	that	cst
the	the	at
patient	patient	nn1
had	have	vhd
also	also	rr
experienced	experience	vvn
a	a	at1
relapse	relapse	nn1
of	of	io
his	his	appge
chronic	chronic	jj
myelogenous	myelogenous	jj
leukemia	leukemia	nn1
.	.	y
Rapid	rapid	jj
initiation	initiation	nn1
of	of	io
chemotherapy	chemotherapy	nn1
produced	produce	vvd_vvn
a	a	at1
substantial	substantial	jj
decrease	decrease	nn1
in	in	ii
tumor	tumor	nn1
bulk	bulk	nn1
.	.	y
Figure	figure	nn1
2	2	mc
.	.	y
Endoscopic	endoscopic	jj
view	view	nn1
shows	show	vvz
the	the	at
gross	gross	jj
appearance	appearance	nn1
of	of	io
the	the	at
mass	mass	nn1_jj
.	.	y
Figure	figure	nn1
3	3	mc
.	.	y
The	the	at
tumor	tumor	nn1
consists	consist	vvz
of	of	io
atypical	atypical	jj
round	round	jj
cells	cell	nn2
with	with	iw
irregular	irregular	jj
nuclei	nucleus	nn2
(	(	y
H	h	zz1
&E).;		null
Discussion	discussion	nn1
In	in	ii31
addition	addition	ii32
to	to	ii33
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
,	,	y
the	the	at
differential	differential	jj_nn1
diagnosis	diagnosis	nn1
of	of	io
hematolymphoid	hematolymphoid	jj_nn1
tumors	tumor	nn2
of	of	io
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
includes	include	vvz
non-Hodgkin	non-hodgkin	np1
lymphoma	lymphoma	nn1
,	,	y
diffuse	diffuse	vv0_jj
large	large	jj
B-cell	b-cell	jj_nn1
lymphoma	lymphoma	nn1
,	,	y
extramedullary	extramedullary	jj_nn1
plasmacytoma	plasmacytoma	nn1
,	,	y
histiocytic	histiocytic	jj
sarcoma	sarcoma	nn1
,	,	y
and	and	cc
Langerhans	langerhans	np2
cell	cell	nn1
histiocytosis.		nnu
(	(	y
n14	n14	fo
,	,	y
n15	n15	fo
)	)	y
Making	make	vvg
the	the	at
correct	correct	jj
diagnosis	diagnosis	nn1
of	of	io
these	these	dd2
relatively	relatively	rr
rare	rare	jj
tumors	tumor	nn2
can	can	vm
be	be	vbi
challenging	challenging	jj_vvg
,	,	y
especially	especially	rr
those	those	dd2
that	that	cst
are	be	vbr
poorly	poorly	rr
differentiated	differentiate	vvn
variants.		nnu
n15	n15	fo
Granulocytic	granulocytic	jj_nn1
sarcoma	sarcoma	nn1
is	be	vbz
often	often	rr
mistaken	mistake	vvn
for	for	if
lymphoma	lymphoma	nn1
or	or	cc
other	other	jj
poorly	poorly	rr_jj
differentiated	differentiate	vvn_vvd_jj%
malignancies	malignancy	nn2
,	,	y
and	and	cc
the	the	at
correct	correct	jj
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
clinician	clinician	nn1
should	should	vm
be	be	vbi
alerted	alert	vvn
to	to	ii
the	the	at
possibility	possibility	nn1
of	of	io
this	this	dd1
diagnosis	diagnosis	nn1
by	by	ii
a	a	at1
finding	finding	nn1
of	of	io
a	a	at1
less	less	rgr
differentiated	differentiated	jj%
neoplasm	neoplasm	nn1
combined	combine	vvn
with	with	iw
pathologic	pathologic	jj
evidence	evidence	nn1
of	of	io
myeloid	myeloid	jj_nn1
differentiation	differentiation	nn1
in	in	ii
the	the	at
presence	presence	nn1
of	of	io
positive	positive	jj
testing	testing	nn1
for	for	if
chloroacetate	chloroacetate	nn1
esterase	esterase	nn1_vv0
,	,	y
myeloperoxidase	myeloperoxidase	vv0_nn1
,	,	y
lysozyme	lysozyme	nn1
,	,	y
CD43	cd43	fo
,	,	y
CD79a	cd79a	fo
,	,	y
or	or	cc
CD3.		fo
n16	n16	fo
Cytopathology	cytopathology	nn1_np1
is	be	vbz
very	very	rg
accurate	accurate	jj
in	in	ii
diagnosing	diagnose	vvg
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
.	.	y
In	in	ii
fact	fact	nn1
,	,	y
one	one	mc1
study	study	nn1
found	find	vvd_vvn
that	that	cst_dd1
26	26	mc
of	of	io
27	27	mc
cases	case	nn2
were	be	vbdr
correctly	correctly	rr
diagnosed	diagnose	vvn_vvd
on	on	ii
fine-needle	fine-needle	jj_nn1
aspiration	aspiration	nn1
;	;	y
the	the	at
lone	lone	jj
nondiagnostic	nondiagnostic	jj
case	case	nn1
was	be	vbdz
subsequently	subsequently	rr
diagnosed	diagnose	vvn_vvd
as	as	ii
a	a	at1
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
on	on	ii
open	open	jj_rr@
biopsy.	biopsy	nnu
n17	n17	fo
Cytogenetic	cytogenetic	jj_nn1
analysis	analysis	nn1
of	of	io
the	the	at
tumor	tumor	nn1
and	and	cc
bone	bone	nn1
marrow	marrow	nn1
may	may	vm
aid	aid	vvi
in	in	ii
the	the	at
confirmation	confirmation	nn1
of	of	io
a	a	at1
presumptive	presumptive	jj
diagnosis	diagnosis	nn1
when	when	cs_rrq
immunohistochemical	immunohistochemical	jj
studies	study	nn2
produce	produce	vv0
conflicting	conflicting	jj
results	result	nn2
or	or	cc
when	when	rrq_cs
bone	bone	nn1
marrow	marrow	nn1
involvement	involvement	nn1
in	in	ii
leukemia	leukemia	nn1
lags	lag	vvz_nn2
behind	behind	ii
peripheral	peripheral	jj
manifestations.	manifestation	nnu
n18	n18	fo
While	while	cs
the	the	at
diagnosis	diagnosis	nn1
in	in	ii
our	our	appge
case	case	nn1
was	be	vbdz
aided	aid	vvn
by	by	ii
our	our	appge
knowledge	knowledge	nn1
of	of	io
the	the	at
patient	patient	nn1
's	's	ge
history	history	nn1
of	of	io
chronic	chronic	jj
myelogenous	myelogenous	jj
leukemia	leukemia	nn1
,	,	y
it	it	pph1
may	may	vm
not	not	xx
be	be	vbi
as	as	rg@
easily	easily	rr
reached	reach	vvn_vvd
in	in	ii
patients	patient	nn2
who	who	pnqs
lack	lack	vv0@
any	any	dd
history	history	nn1
of	of	io
known	known	jj@
hematologic	hematologic	jj
abnormalities.	abnormalities	nnu
(	(	y
n17	n17	fo
,	,	y
n19	n19	fo
,	,	y
n20	n20	fo
)	)	y
So	so	rr_cs@
again	again	rt
,	,	y
it	it	pph1
is	be	vbz
imperative	imperative	jj
that	that	cst
clinicians	clinician	nn2
maintain	maintain	vv0
a	a	at1
high	high	jj
index	index	nn1
of	of	io
suspicion	suspicion	nn1
for	for	if
this	this	dd1
relatively	relatively	rr
rare	rare	jj
entity	entity	nn1
because	because	cs
studies	study	nn2
have	have	vh0
shown	show	vvn
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
to	to	ii
overt	overt	jj
leukemia	leukemia	nn1
if	if	cs
isolated	isolated	jj_vvn
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
is	be	vbz
treated	treat	vvn
appropriately	appropriately	rr
with	with	iw
systemic	systemic	jj
chemotherapy.	chemotherapy	nnu
n21	n21	fo
In	in	rr21
addition	addition	rr22
,	,	y
a	a	at1
prompt	prompt	jj_nn1
diagnosis	diagnosis	nn1
prior	prior	ii21
to	to	ii22
any	any	dd
bone	bone	nn1
marrow	marrow	nn1
involvement	involvement	nn1
may	may	vm
help	help	vvi
improve	improve	vvi
the	the	at
cure	cure	nn1
rate.	rate	nnu
n22	n22	fo
Even	even	cs21
when	when	cs22
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
appears	appear	vvz
to	to	to
be	be	vbi
isolated	isolate	vvn
,	,	y
it	it	pph1
is	be	vbz
most	most	rgt
likely	likely	jj_rr@
a	a	at1
partial	partial	jj
manifestation	manifestation	nn1
of	of	io
a	a	at1
systemic	systemic	jj
disease	disease	nn1
.	.	y
Therefore	therefore	rr
,	,	y
some	some	dd
authors	author	nn2
advocate	advocate	vv0
that	that	cst
patients	patient	nn2
should	should	vm
be	be	vbi
treated	treat	vvn
with	with	iw
aggressive	aggressive	jj
systemic	systemic	jj
chemotherapy	chemotherapy	nn1
(	(	y
i.e.	ie	rex
,	,	y
the	the	at
acute	acute	jj
nonlymphocytic	nonlymphocytic	jj
leukemia	leukemia	nn1
protocol	protocol	nn1
)	)	y
to	to	to
potentially	potentially	rr
prevent	prevent	vvi
progression	progression	nn1
to	to	ii
systemic	systemic	jj
leukemia.	leukemia	nnu
(	(	y
n2	n2	fo
,	,	y
n19	n19	fo
,	,	y
n20	n20	fo
)	)	y
Surgery	surgery	nn1
and	and	cc
radiation	radiation	nn1
therapy	therapy	nn1
do	do	vd0
not	not	xx
appear	appear	vvi
to	to	to
play	play	vvi
a	a	at1
role	role	nn1
in	in	ii
the	the	at
treatment	treatment	nn1
of	of	io
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
except	except	cs_ii
in	in	ii
cases	case	nn2
of	of	io
residual	residual	jj
or	or	cc
symptomatic	symptomatic	jj
disease.	disease	nnu
(	(	y
n19	n19	fo
,	,	y
n21	n21	fo
)	)	y
In	in	ii
conclusion	conclusion	nn1
,	,	y
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
is	be	vbz
a	a	at1
rare	rare	jj
hematologic	hematologic	jj
abnormality	abnormality	nn1
that	that	cst_dd1
can	can	vm
be	be	vbi
effectively	effectively	rr
treated	treat	vvn
if	if	cs
diagnosed	diagnose	vvn
early	early	rr_jj
and	and	cc
treated	treat	vvn_vvd@
promptly	promptly	rr
with	with	iw
aggressive	aggressive	jj
systemic	systemic	jj
chemotherapy	chemotherapy	nn1
.	.	y
While	while	cs
the	the	at
diagnosis	diagnosis	nn1
of	of	io
this	this	dd1
tumor	tumor	nn1
has	have	vhz
become	become	vvn@
more	more	rgr
accurate	accurate	jj
,	,	y
especially	especially	rr
in	in	ii
patients	patient	nn2
who	who	pnqs
have	have	vh0
a	a	at1
history	history	nn1
of	of	io
hematologic	hematologic	jj
abnormalities	abnormality	nn2
,	,	y
it	it	pph1
is	be	vbz
important	important	jj
to	to	to
keep	keep	vvi
this	this	dd1
rare	rare	jj
entity	entity	nn1
in	in	ii
mind	mind	nn1
when	when	cs_rrq
faced	face	vvn
with	with	iw
poorly	poorly	rr_jj
differentiated	differentiate	vvn_vvd_jj%
neoplasms	neoplasm	nn2
of	of	io
the	the	at
head	head	nn1
and	and	cc
neck	neck	nn1
in	in	bcl21
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
:	:	y
The	the	at
information	information	nn1
in	in	ii
this	this	dd1
article	article	nn1
has	have	vhz
been	be	vbn
updated	update	vvn
from	from	ii
its	its	z'
original	original	jj
form	form	nn1
as	as	ii_csa
a	a	at1
poster	poster	nn1
presentation	presentation	nn1
at	at	ii
the	the	at
Triological	triological	jj
Society	society	nn1
's	's	ge_vbz
Combined	combined	jj_vvn
Otolaryngological	otolaryngological	jj
Spring	spring	nn1
Meeting	meeting	nn1
;	;	y
May	may	npm1
19-22	19-22	mcmc
,	,	y
2006	2006	mc
;	;	y
Chicago	chicago	np1
References	reference	nn2
(	(	y
n1	n1	fo
.	.	y
)	)	y
Neiman	neiman	nn1_np1@
RS	rs	nn1
,	,	y
Barcos	barco	np2_nn2@
M	m	nn1_zz1
,	,	y
Berard	berard	np1
C	c	np1_zz1
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
:	:	y
A	a	zz1_at1@
clinicopathologic	clinicopathologic	jj
study	study	nn1
of	of	io
61	61	mc
biopsied	biopsied	jj@_vvd
cases	case	nn2
.	.	y
Cancer	cancer	nn1
1981	1981	mc
;	;	y
48(6):1426-37.		fo
(	(	y
n2	n2	fo
.	.	y
)	)	y
Meis	meis	np1@
JM	jm	np1
,	,	y
Butler	butler	np1
JJ	xx_jj	np1
,	,	y
Osborne	osborne	np1
BM	bm	np1
,	,	y
Manning	manning	np1
JT	jt	np1
.	.	y
Granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
in	in	ii
nonleukemic	nonleukemic	jj
patients	patient	nn2
.	.	y
Cancer	cancer	nn1
1986	1986	mc
;	;	y
58(12):2697-2709.		fo
(	(	y
n3	n3	fo
.	.	y
)	)	y
Stockl	stockl	vv0_np1@
FA	fa	np1
,	,	y
Dolmetsch	dolmetsch	np1
AM	am	ra@
,	,	y
Saornil		np1
MA	ma	nna
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Orbital	orbital	jj
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
.	.	y
Br	br	np1@_jj
J	xx_j	np1@_zz1
Ophthalmol	ophthalmol	np1_vv0_nn1
1997	1997	mc
;	;	y
81(12):1084-8.		fo
(	(	y
n4	n4	fo
.	.	y
)	)	y
Lee	lee	np1
SS	ss	np1
,	,	y
Kim	kim	np1
HK	hk	np1
,	,	y
Choi	choi	np1_nn1
SC	sc	fo
,	,	y
Lee	lee	np1
JI	ji	np1_nn1_nn2
.	.	y
Granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
occurring	occur	vvg
in	in	ii
the	the	at
maxillary	maxillary	jj_nn1
gingiva	gingiva	nn1
demonstrated	demonstrate	vvn
by	by	ii
magnetic	magnetic	jj
resonance	resonance	nn1
imaging	imaging	nn1_vvg
.	.	y
Oral	oral	jj_nn1
Surg	surg	nn1_np1_vv0
Oral	oral	jj_nn1
Med	med	jj
Oral	oral	jj_nn1
Pathol	pathol	nn1_vv0_np1
Oral	oral	nn1_jj
Radiol		np1_nn1
Endod		np1
2001	2001	mc
;	;	y
92	92	mc
(	(	y
6	6	mc
)	)	y
:	:	y
689-93.		mcmc
(	(	y
n5	n5	fo
.	.	y
)	)	y
Goteri		np1@_nn2
G	g	zz1_np1@
,	,	y
Ascani		np1_jj
G	g	zz1_np1@
,	,	y
Messi		np1_jj
M	m	zz1_nn1
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Myeloid	myeloid	jj_nn1
sarcoma	sarcoma	nn1
of	of	io
the	the	at
maxillary	maxillary	jj_nn1
bone	bone	nn1
.	.	y
J	xx_j	zz1
Oral	oral	jj
Pathol	pathol	nn1_np1
Med	m	vvd@_jj
2006	2006	mc
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
B	b	zz1_np1@
,	,	y
Kumar	kumar	np1
S	s	zz1_np1@
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Facial	facial	jj
palsy	palsy	nn1
as	as	ii_csa
the	the	at
first	first	md
presentation	presentation	nn1
of	of	io
acute	acute	jj
myeloid	myeloid	jj_nn1
leukemia	leukemia	nn1
.	.	y
Am	be	vbm
J	xx_j	np1@
Hematol	hematol	np1_nn1
2003	2003	mc
;	;	y
74(3):200-1.		fo
(	(	y
n7	n7	fo
.	.	y
)	)	y
Dikbas		np1@_nn2
O	o	zz1_np1@
,	,	y
Isik	isik	np1_nn1
M	m	zz1_nn1
,	,	y
Purnak		np1
T	t	zz1_np1@
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Isolated	isolated	jj
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
of	of	io
the	the	at
head	head	nn1
and	and	cc
neck	neck	nn1_vv0@
preceding	precede	vvg_jj
acute	acute	jj
myeloid	myeloid	jj_nn1
leukemia	leukemia	nn1
.	.	y
Am	be	vbm
J	xx_j	np1@
Hematol	hematol	np1_nn1
2004	2004	mc
;	;	y
76	76	mc
(	(	y
1	1	mc1
)	)	y
:	:	y
95	95	mc
-6.	-6.	mc
(	(	y
n8	n8	fo
.	.	y
)	)	y
Cankaya	cankaya	nn1_np1@
H	h	zz1_np1@
,	,	y
Ugras		nn2@_np2
S	s	zz1_np1@
,	,	y
Dilek		np1
I.	i	np1
Head	head	nn1
and	and	cc
neck	neck	vv0@_nn1
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
with	with	iw
acute	acute	jj
myeloid	myeloid	jj_nn1
leukemia	leukemia	nn1
:	:	y
Three	three	mc
rare	rare	jj
cases	case	nn2
.	.	y
Ear	ear	nn1
Nose	nose	nn1
Throat	throat	nn1
J	xx_j	zz1
2001	2001	mc
;	;	y
80(4):224-6		fo
,	,	y
228-9.		mcmc
(	(	y
n9	n9	fo
.	.	y
)	)	y
Thomas	thomas	np1
RF	rf	np1
,	,	y
Kerr	kerr	np1
JT	jt	np1
,	,	y
Eusterman	eusterman	np1_nn1
VD	vd	nn1
.	.	y
Granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
presenting	present	vvg
with	with	iw
facial	facial	jj
nerve	nerve	nn1
paralysis	paralysis	nn1
and	and	cc
otalgia	otalgia	nn1
abstract	abstract	nn1@_jj
.	.	y
Otolaryngol	otolaryngol	vv0_nn1
Head	head	nn1
Neck	neck	nn1
Surg	surg	nn1_np1_vv0
2005	2005	mc
;	;	y
133		vv0_nn1_jj
(	(	y
2	2	jj_vv0_nn1
Suppl	suppl	nn1_np1
)	)	y
:	:	y
241.	241	mc
(	(	y
n10	n10	fo
.	.	y
)	)	y
Gokcan		np1@
MK	mk	np1
,	,	y
Batikhan		np1
H	h	zz1_np1@
,	,	y
Calgunar		np1_jj
M	m	zz1_nn1
,	,	y
Tataragasi	tataragasi	jj_np1
AI	ai	nn1
.	.	y
Unilateral	unilateral	jj
hearing	hearing	nn1
loss	loss	nn1
as	as	ii_csa
a	a	at1
presenting	presenting	nn1@
manifestation	manifestation	nn1
of	of	io
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
(	(	y
chloroma	chloroma	nn1
)	)	y
.	.	y
Otol	otol	vv0_np1@_nn1
Neurotol	neurotol	nn1_np1_vv0
2006	2006	mc
;	;	y
27(1):106-9.		fo
(	(	y
n11	n11	fo
.	.	y
)	)	y
Bassichis	bassichis	nn1_np1@
B	b	zz1_np1@
,	,	y
McClay	mcclay	np1
J	xx_j	zz1_np1@
,	,	y
Wiatrak	wiatrak	np1
B.	b	np1
Chloroma		np1_nn1@
of	of	io
the	the	at
masseteric	masseteric	jj
muscle	muscle	nn1
.	.	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
)	)	y
Prades	prades	np1@
JM	jm	np1
,	,	y
Alaani		np1_jj_nn1
A	a	zz1
,	,	y
Mosnier	mosnier	np1_nn1_jjr
IF	if	cs
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
of	of	io
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
.	.	y
Rhinology	rhinology	nn1_np1@
2002	2002	mc
;	;	y
40(3):159-61.		fo
(	(	y
n13	n13	fo
.	.	y
)	)	y
Ferri	ferri	np1@_nn2
E	e	zz1_np1@
,	,	y
Minotto		np1
C	c	np1_zz1
,	,	y
Ianniello	ianniello	np1
F	f	zz1_np1@
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Maxillo-ethmoidal	maxillo-ethmoidal	jj
chloroma	chloroma	nn1
in	in	ii
acute	acute	jj
myelogenous	myelogenous	jj
leukemia	leukemia	nn1
:	:	y
Case	case	nn1
report	report	nn1
.	.	y
Acta	acta	np1@_nn1
Otorhinolaryngol		np1
Ital	ital	np1
2005	2005	mc
;	;	y
25(3):195-9.		fo
(	(	y
n14	n14	fo
.	.	y
)	)	y
Barnes	barnes	np1
l	l	zz1
,	,	y
Eveson	eveson	np1
JW	jw	np1
,	,	y
Reichart	reichart	np1
P	xx_p	zz1_np1@
,	,	y
Sidransky	sidransky	np1
D	d	zz1_np1@
,	,	y
eds	ed	nn2
.	.	y
Pathology	pathology	nn1
and	and	cc
Genetics	genetics	nn1
:	:	y
Head	head	nn1_vv0@_jj@
and	and	cc
Neck	neck	nn1_vv0@
Tumours	tumor	nn2
.	.	y
Kleihues		np1@_nn2
P	xx_p	zz1_np1@
,	,	y
Sobin	sobin	np1
LH	lh	np1
,	,	y
series	series	nn
eds	ed	nn2
.	.	y
World	world	nn1
Health	health	nn1
Organization	organization	nn1
Classification	classification	nn1
of	of	io
Tumours	tumor	nn2
.	.	y
Lyon	lyon	np1
,	,	y
France	france	np1
:	:	y
IARC	iarc	np1_nn1
Press	press	nn1_vv0
,	,	y
2005.	2005	mc
(	(	y
n15	n15	fo
.	.	y
)	)	y
Dulguerov		np1
P	xx_p	zz1_np1@
,	,	y
Allal	allal	jj_np1
AS	as	csa
,	,	y
Calcaterra	calcaterra	np1
TC	tc	np1
.	.	y
Esthesioneuroblastoma		np1@_nn1
:	:	y
A	a	at1@_zz1
meta-analysis	meta-analysis	nn1
and	and	cc
review	review	nn1_vv0
.	.	y
Lancet	lancet	np1
Oncol	oncol	np1_nn1
2001	2001	mc
;	;	y
2(11):683-90.		fo
(	(	y
n16	n16	fo
.	.	y
)	)	y
Menasce	menasce	vv0_np1@
LP	lp	nn1
,	,	y
Banerjee	banerjee	np1
SS	ss	np1
,	,	y
Beckett	beckett	np1
E	e	zz1_np1@
,	,	y
Harris	harris	np1
M.	m	nn1
Extra-medullary	extra-medullary	jj_nn1
myeloid	myeloid	jj_nn1
tumour	tumor	nn1
(	(	y
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
)	)	y
is	be	vbz
often	often	rr
misdiagnosed	misdiagnose	vvn
:	:	y
A	a	at1@_zz1
study	study	nn1
of	of	io
26	26	mc
cases	case	nn2
.	.	y
Histopathology	histopathology	nn1_np1@
1999	1999	mc
;	;	y
34(5):391-8.		fo
(	(	y
n17	n17	fo
.	.	y
)	)	y
Suh	suh	np1@_nn1
YK		np1_nn1
,	,	y
Shin	shin	nn1
HJ	hj	np1
.	.	y
Fine-needle	fine-needle	jj_nn1
aspiration	aspiration	nn1
biopsy	biopsy	nn1
of	of	io
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
:	:	y
A	a	zz1_at1@
clinicopathologic	clinicopathologic	jj
study	study	nn1
of	of	io
27	27	mc
cases	case	nn2
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
)	)	y
Choo	choo	nn1_np1@
PH	ph	nn1
,	,	y
Arain	arain	jj_nn1_vv0@
SA	sa	np1
,	,	y
Carolan	carolan	np1
JA	ja	np1_fw
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Extramedullary	extramedullary	jj
myeloid	myeloid	jj_nn1
leukemia	leukemia	nn1
:	:	y
The	the	at
value	value	nn1
of	of	io
cytogenetic	cytogenetic	jj
analysis	analysis	nn1
in	in	ii
pediatric	pediatric	jj
orbital	orbital	jj
tumors	tumor	nn2
.	.	y
Ophthal		np1@_jj
Plast	plast	np1_nn1
Reconstr		np1
Surg	surg	np1_nn1
2006	2006	mc
;	;	y
22	22	mc
(	(	y
2	2	mc
)	)	y
:	:	y
143-5.		mcmc
(	(	y
n19	n19	fo
.	.	y
)	)	y
Byrd	byrd	np1@
JC	jc	np1
,	,	y
Edenfield	edenfield	np1
WJ	wj	np1
,	,	y
Shields	shield	vvz_np1@
DJ	dj	nn1
,	,	y
Dawson	dawson	np1
NA	na	fw_fu_fo@
.	.	y
Extramedullary	extramedullary	jj
myeloid	myeloid	jj_nn1
cell	cell	nn1
tumors	tumor	nn2
in	in	ii
acute	acute	jj
nonlymphocytic	nonlymphocytic	jj
leukemia	leukemia	nn1
:	:	y
A	a	zz1_at1@
clinical	clinical	jj
review	review	nn1
.	.	y
J	xx_j	np1@_zz1
Clin	clin	np1
Oncol	oncol	np1_nn1
1995	1995	mc
;	;	y
13(7):1800-16.		fo
(	(	y
n20	n20	fo
.	.	y
)	)	y
Yamauchi	yamauchi	np1@_nn2
K	k	zz1_np1@
,	,	y
Yasuda	yasuda	np1
M.	m	nn1
Comparison	comparison	nn1
in	in	ii
treatments	treatment	nn2
of	of	io
nonleukemic	nonleukemic	jj
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
:	:	y
Report	report	nn1
of	of	io
two	two	mc
cases	case	nn2
and	and	cc
a	a	at1
review	review	nn1
of	of	io
72	72	mc
cases	case	nn2
in	in	ii
the	the	at
literature	literature	nn1
.	.	y
Cancer	cancer	nn1
2002	2002	mc
;	;	y
94(6):1739-46.		fo
(	(	y
n21	n21	fo
.	.	y
)	)	y
Imrie	imrie	np1@
KR	kr	np1
,	,	y
Kovacs	kovacs	np2_nn2@
MJ	mj	np1
,	,	y
Selby	selby	np1
D	d	zz1_np1@
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Isolated	isolated	jj
chloroma	chloroma	nn1
:	:	y
The	the	at
effect	effect	nn1
of	of	io
early	early	jj_rr
antileukemic	antileukemic	jj
therapy	therapy	nn1
.	.	y
Ann	ann	np1
Intern	intern	np1
Med	m	vvd@_jj
1995	1995	mc
;	;	y
123(5):351-3.		fo
(	(	y
n22	n22	fo
.	.	y
)	)	y
Martinelli	martinelli	np1@_nn2
G	g	zz1_np1@
,	,	y
Ottaviani	ottaviani	np1_jj
E	e	zz1_np1@
,	,	y
Testoni	testoni	np1_jj
N	xx_n	zz1_np1@
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Molecular	molecular	jj
analysis	analysis	nn1
of	of	io
granulocytic	granulocytic	jj
sarcoma	sarcoma	nn1
:	:	y
A	a	zz1_at1@
single	single	jj
center	center	nn1
experience	experience	nn1
.	.	y
Haemotologica	haemotologica	nn1_np1@
1999	1999	mc
;	;	y
84(4):380-2		fo
.	.	y
By	by	ii
Mary	mary	np1
Gorman	gorman	np1
,	,	y
MD	md	nna
;	;	y
Khwaja	khwaja	np1
Asif	asif	np1
Ahmed	ahmed	np1
,	,	y
MD	md	nna
;	;	y
Arnel	arnel	np1
Pallera		np1
,	,	y
MD	md	nna
and	and	cc
Sandeep	sandeep	np1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
of	of	io
Tennessee	tennessee	np1
Health	health	nn1
Science	science	nn1
Center	center	nn1
,	,	y
Memphis	memphis	np1
.	.	y
Corresponding	corresponding	jj_vvg
author	author	nn1
:	:	y
K.	k	np1
Asif	asif	np1
Ahmed	ahmed	np1
,	,	y
MD	md	nna
,	,	y
The	the	at
Jackson	jackson	np1
Clinic	clinic	nn1
,	,	y
616	616	mc
W.	w	nnu@_np1_nd1@
Forest	forest	nn1
Ave.	average	np1
,	,	y
Jackson	jackson	np1
,	,	y
TN	tn	np1
38301	38301	mc
.	.	y
E-mail	e-mail	nn1_vv0@
:	:	y
asif74@hotmail.com		fo
